The ROE as of November 2024 (TTM) for CollPlant Biotechnologies Ltd. (CLGN) is -65.98%

According to CollPlant Biotechnologies Ltd.’s latest financial reports and current stock price. The company's current ROE is -65.98%. This represents a change of 290.86% compared to the average of -16.88% of the last 4 quarters.

CollPlant Biotechnologies Ltd. (CLGN) Historical ROE (quarterly & annually)

How has CLGN ROE performed in the past?

The mean historical ROE of CollPlant Biotechnologies Ltd. over the last ten years is -174.95%. The current -65.98% ROE has changed -62.29% with respect to the historical average. Over the past ten years (40 quarters), CLGN's ROE was at its highest in in the September 2019 quarter at 234.04%. The ROE was at its lowest in in the September 2017 quarter at -186.36%.

CollPlant Biotechnologies Ltd. (CLGN) ROE by Quarter and Year

Discovering the peaks and valleys of CollPlant Biotechnologies Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

CollPlant Biotechnologies Ltd. (CLGN) Average ROE

How has CLGN ROE performed in the past?

The current ROE of CollPlant Biotechnologies Ltd. (CLGN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

CollPlant Biotechnologies Ltd. (CLGN) ROE vs. Peers

How is CLGN’s ROE compared to its peers?

CollPlant Biotechnologies Ltd.’s ROE is greater than Keros Therapeutics, Inc. (-44.73%), greater than Merus N.V. (-45.38%), less than Vericel Corporation (0.35%), greater than Century Therapeutics, Inc. (-65.37%), greater than Shattuck Labs, Inc. (-68.65%), greater than C4 Therapeutics, Inc. (-42.45%), greater than Eliem Therapeutics, Inc. (-47.03%), greater than Prelude Therapeutics Incorporated (-59.82%), greater than Monte Rosa Therapeutics, Inc. (-70.40%), greater than Molecular Partners AG (-33.08%), greater than MediciNova, Inc. (-13.37%), greater than Anebulo Pharmaceuticals, Inc. (-138.92%), less than Champions Oncology, Inc. (323.52%), greater than Cyteir Therapeutics, Inc. (-23.13%), greater than Replimune Group, Inc. (-52.15%), greater than Crinetics Pharmaceuticals, Inc. (-62.63%), greater than NewAmsterdam Pharma Company N.V. (-86.66%), greater than PureTech Health plc (-26.28%), greater than Ikena Oncology, Inc. (-42.81%), greater than Enochian Biosciences, Inc. (-47.54%), greater than HCW Biologics Inc. (-385.90%), greater than Exicure, Inc. (-288.03%),

Build a custom stock screener for CollPlant Biotechnologies Ltd. (CLGN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like CollPlant Biotechnologies Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

CollPlant Biotechnologies Ltd. (CLGN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like CollPlant Biotechnologies Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.